Daizoh Satoh

Daizoh Satoh

Auto-generated profile, based on publicly available information

Daizoh Satoh

Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

15 May 2012 in Journal of Anesthesia
Verified
Journal Article
Open access
PDF file
DSDaizoh Satoh
Daizoh Satoh
SKShin Kurosawa
Shin Kurosawa
WKWakaba Kirino
Wakaba Kirino
TWToshihiro Wagatsuma
Toshihiro Wagatsuma
YEYutaka Ejima
Yutaka Ejima
KNKei Nagaya
Kei Nagaya
Purpose Several reports in the literature have described the effects of positive end-expiratory pressure (PEEP) level upon functional residual capacity (FRC) in ventilated patients during general anesthesia. This study compares FRC in mechanically low tidal volume ventilation with different PEEP levels during upper abdominal surgery. Methods Before induction of anesthesia (awake) for nine patients with upper abdominal surgery, a tight-seal facemask was applied with 2 cmH2O pressure support ventilation and 100 % O2 during FRC measurements conducted on patients in a supine position. After tracheal intubation, lungs were ventilated with bilevel airway pressure with a volume guarantee (7 ml/kg predicted body weight) and with an inspired oxygen fraction (FIO2) of 0.4. PEEP levels of 0, 5, and 10 cmH2O were used. Each level of 5 and 10 cmH2O PEEP was maintained for 2 h. FRC was measured at each PEEP level. Results FRC awake was significantly higher than that at PEEP 0 cmH2O (P < 0.01). FRC at PEEP 0 cmH2O was significantly lower than that at 10 cmH2O (P < 0.01). PaO2/FIO2 awake was significantly higher than that for PEEP 0 cmH2O (P < 0.01). PaO2/FIO2 at PEEP 0 cmH2O was significantly lower than that for PEEP 5 cmH2O or PEEP 10 cmH2O (P < 0.01). Furthermore, PEEP 0 cmH2O, PEEP 5 cmH2O after 2 h, and PEEP 10 cmH2O after 2 h were correlated with FRC (R = 0.671, P < 0.01) and PaO2/FIO2 (R = 0.642, P < 0.01). Conclusions Results suggest that PEEP at 10 cmH2O is necessary to maintain lung function if low tidal volume ventilation is used during upper abdominal surgery.

1 January 2005 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KHKunihiko Hoshi
Kunihiko Hoshi
SKShin Kurosawa
Shin Kurosawa
MKMasato Kato
Masato Kato
KAKohkichi Andoh
Kohkichi Andoh
DSDaizoh Satoh
Daizoh Satoh
AKAtsushi Kaise
Atsushi Kaise
Many studies have suggested that neutrophil elastase (NE) may contribute to multiple organ failure (MOF) and acute injury of lung endothelial cells. It is therefore conceivable that NE inhibitors may improve the outcome of MOF patients. A synthetic NE inhibitor, sivelestat, which was developed and released in Japan, inhibited inflammatory reactions in various animal models. We examined the medical records of patients requiring more than two days of respiratory care in four intensive care units to investigate whether sivelestat contributed to improvement of their conditions. A total of 110 patients were divided into two groups (sivelestat treated group of 57 patients and untreated group of 53 patients). The conditions and age of the patients were similar in both groups. Sivelestat (0.2 mg/kg/hr) was administered continuously for 14 days beginning on the day of the intensive care unit (ICU) admission or for less than 14 days until discharge from the ICU. Hospital mortality differed significantly between the two groups (treated: 19% and untreated: 40%, p < 0.05). The severity of acute lung injury is defined by the ratio of arterial oxygen partial pressure (PaO2)/fraction concentration of oxygen in the inspired air (FiO2). When the PaO2/FiO2 ratio is more than 200 mmHg, the morbidity is lower. In patients with PaO2/FiO2 ratio more than 200 mmHg, the hospital mortality was 33.3% (7/21) in the untreated group and 6.0% (1/18) in the treated group (p = 0.0236). We conclude that administration of sivelestat reduces mortality of critically ill patients.

12 October 2018 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
CMChieko Mitaka
Chieko Mitaka
MOMasahiko Odoh
Masahiko Odoh
DSDaizoh Satoh
Daizoh Satoh
THTadasuke Hashiguchi
Tadasuke Hashiguchi
EIEiichi Inada
Eiichi Inada
Weaning from prolonged mechanical ventilation is extremely difficult in tracheostomized patients with restrictive pulmonary dysfunction. High-flow oxygen via tracheostomy supplies heated and humidified oxygen gas at > 10 L/minute. However, little has been reported on the use of high-flow oxygen via tracheostomy during weaning from ventilators in patients with restrictive pulmonary dysfunction. We report successful weaning from ventilators in patients with restrictive pulmonary dysfunction using high-flow oxygen via tracheostomy. The first patient is a 78-year-old Japanese man with severe pneumococcal pneumonia who was mechanically ventilated for more than 1 month after esophagectomy for esophageal cancer. After he underwent tracheostomy because of prolonged mechanical ventilation, restrictive pulmonary dysfunction appeared: tidal volume 230–240 mL and static compliance 14–15 mL/cmH2O with 10 cmH2O pressure support ventilation. He was weaned from the ventilator under inspiratory support with high-flow oxygen via tracheostomy over a period of 16 days (flow at 40 L/minute and fraction of inspired oxygen of 0.25). The second patient is a 69-year-old Japanese man who developed aspiration pneumonia after esophagectomy and received prolonged mechanical ventilation via tracheostomy. He developed restrictive pulmonary dysfunction. High-flow oxygen via tracheostomy (flow at 40 L/minute with fraction of inspired oxygen of 0.25) was administered with measurement of the airway pressure and at the entrance of the tracheostomy tube. The measured values were as follows: 0.21–0.3 cmH2O, 0.21–0.56 cmH2O, 0.54–0.91 cmH2O, 0.76–2.01 cmH2O, 1.17–2.01 cmH2O, and 1.76–2.01 cmH2O at 10 L/minute, 20 L/minute, 30 L/minute, 40 L/minute, 50 L/minute, and 60 L/minute, respectively. The airway pressures were continuously positive and did not become negative even during inspiration, suggesting that high-flow oxygen via tracheostomy reduces inspiratory effort. He was weaned from the ventilator under inspiratory support with high-flow oxygen via tracheostomy over a period of 12 days. High-flow oxygen via tracheostomy may reduce the inspiratory effort and enhance tidal volume by delivering high-flow oxygen and facilitate weaning from prolonged mechanical ventilation in patients with restrictive pulmonary dysfunction.

1 February 2017 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
PDF file
IKIzumi Kawagoe
Izumi Kawagoe
MHMasakazu Hayashida
Masakazu Hayashida
YNYusaku Nozumi
Yusaku Nozumi
TBTakamitsu Banno
Takamitsu Banno
SHShunki Hirayama
Shunki Hirayama
EIEiichi Inada
Eiichi Inada
PARTIAL ANOMALOUS PULMONARY venous connection (PAPVC) is a relatively uncommon congenital anomaly, with a reported incidence of 0.4% to 0.7% in the general population.1 x 1 Hughes, C.W. and Rumore, P.C. Anomalous pulmonary veins. Arch Pathol. 1944; 37: 364–366 Google Scholar See all References , 2 x 2 Healey, J.E. Jr. An anatomic survey of anomalous pulmonary veins: Their clinical significance. J Thorac Surg. 1952; 23: 433–444 PubMed | Google Scholar See all References In children, PAPVCs commonly are associated with atrial septal defects (ASDs) and are located primarily on the right side.3 x 3 AboulHosn, J.A., Criley, J.M., and Stringer, W.W. Partial anomalous pulmonary venous return: Case report and review of the literature. Catheter Cardiovasc Interv. 2003; 58: 548–552 Crossref | PubMed | Scopus (23) | Google Scholar See all References , 4 x 4 van de Woestijne, P.C., Verberkmoes, N., and Bogers, A.J. Partial anomalous pulmonary venous connection (including scimitar syndrome). Multimed Man Cardiothorac Surg. 2013; mmt001 Google Scholar See all References In contrast, PAPVCs in adults are found most commonly in the left upper lobe and are very rarely complicated with ASDs.5 x 5 Haramati, L.B., Moche, I.E., and Rivera, V.T. Computed tomography of partial anomalous pulmonary venous connection in adults. J Comput Assist Tomogr. 2003; 7: 743–749 Crossref | Scopus (75) | Google Scholar See all References Surgical correction of a PAPVC is recommended for patients with a pulmonary-to-systemic blood flow ratio (Qp/Qs) of greater than 1.5.3 x 3 AboulHosn, J.A., Criley, J.M., and Stringer, W.W. Partial anomalous pulmonary venous return: Case report and review of the literature. Catheter Cardiovasc Interv. 2003; 58: 548–552 Crossref | PubMed | Scopus (23) | Google Scholar See all References , 6 x 6 El Bardissi, A.W., Dearani, J.A., and Suri, R.M. Left-sided partial anomalous pulmonary venous connections. Ann Thorac Surg. 2008; 85: 1007–1014 Abstract | Full Text | Full Text PDF | PubMed | Scopus (34) | Google Scholar See all References Generally, an isolated PAPVC on the left side can be corrected by a simple procedure without cardiopulmonary bypass (CPB), such as anastomosis of the anomalous vein to the left atrial appendage,6 x 6 El Bardissi, A.W., Dearani, J.A., and Suri, R.M. Left-sided partial anomalous pulmonary venous connections. Ann Thorac Surg. 2008; 85: 1007–1014 Abstract | Full Text | Full Text PDF | PubMed | Scopus (34) | Google Scholar See all References whereas correction of PAPVCs on the right side needs more complicated intracardiac procedures on CPB for rerouting to the left atrium.4 x 4 van de Woestijne, P.C., Verberkmoes, N., and Bogers, A.J. Partial anomalous pulmonary venous connection (including scimitar syndrome). Multimed Man Cardiothorac Surg. 2013; mmt001 Google Scholar See all References

31 May 2021 in Acute and Critical Care
Verified
Journal Article
Open access
PDF file
CMChieko Mitaka
Chieko Mitaka
MKMakio Kusaoi
Makio Kusaoi
IKIzumi Kawagoe
Izumi Kawagoe
DSDaizoh Satoh
Daizoh Satoh
Endotoxin adsorption therapy by polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) has been used for the treatment of septic shock patients. Endotoxin, an outer membrane component of Gram-negative bacteria, plays an important role in the pathogenesis of septic shock. Endotoxin triggers a signaling cascade for leukocytes, macrophage, and endothelial cells to secrete various mediators including cytokines and nitric oxide, leading to septic shock and multiple organ dysfunction syndrome. PMX-DHP directly adsorbed not only endotoxin but also monocytes and anandamide. It reduced blood levels of inflammatory cytokines such as interleukin (IL)-1, IL-6, tumor necrosis factor-alpha and IL-17A, adhesion molecules, plasminogen activator inhibitor 1, and high mobility group box-1. As a result, PMX-DHP increased blood pressure and reduced the dose of vasoactive-inotropic agents. PMX-DHP improved monocyte human leukocyte antigen-DR expression in patients with severe sepsis and septic shock. A post hoc analysis of EUPHRATES (Evaluating the Use of Polymyxin B Hemoperfusion in Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock) trial has shown that PMX-DHP significantly reduced 28-day mortality compared with the control group in septic shock patients with endotoxin activity assay level between 0.60 and 0.89. Longer duration of PMX-DHP may be another strategy to bring out the beneficial effects of PMX-DHP. Further studies are needed to confirm the efficacy of PMX-DHP treatment for septic shock.